Related Experiment Video
Updated: Aug 21, 2026
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
The Trager approach in the treatment of chronic headache: a pilot study
Kimberley A Foster1, Jack Liskin, Steven Cen
1Statistical Consultation and Research Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, USA.
Context:
Although the traditional treatment of headache has been pharmacological, there have been many attempts to treat headaches with other methods with mixed levels of success.
Objective:
To obtain preliminary data on the efficacy of the Trager approach in the treatment of chronic headache.
Design:
Small-scale randomized controlled clinical trial.
Setting:
University-based clinic.
Patients:
Thirty-three volunteers with a self-reported history of chronic headache with at least one headache per week for at least 6 months.
Interventions:
Medication only control group, medication and attention control group, and medication and Trager treatment group.
Main Outcome Measures:
Self-reported frequency, duration, and intensity of headache, medication usage and headache quality of life (HQOL) obtained at baseline and after a 6-week treatment period.
Results:
Analyses of variance demonstrated significant improvement in HQOL for the Trager and attention control groups, and reduction in medication usage for the Trager group (P < 0.05). Within-group analyses revealed that participants randomized to Trager demonstrated a significant decrease in the frequency of headaches (P = 0.045), improvement in HQOL (P = 0.045), and a 44% decrease in medication usage (P = 0.03). Participants randomized to the attention control group demonstrated a significant improvement in HQOL (P = 0.035) and a 19% decrease in medication usage (P = 0.15). Participants randomized to the no-treatment control group revealed a significant increase in headache duration (P = 0.025) and intensity (P = 0.025), and a declination in HQOL (P = 0.035).
Conclusions:
The Trager approach decreased headache frequency and medication usage. Trager and physician attention improved HQOL. A larger, multi-site study is recommended.
